Unanswered questions in including HDL-cholesterol in the cardiovascular risk estimation. Is time still on our side?

被引：6
作者：
Langlois, Michel R. [1 ,2 ]
Delanghe, Joris R. [3 ]
De Buyzere, Marc [1 ]
Rietzschel, Ernst [1 ]
De Bacquer, Dirk [4 ]
机构：
[1] Univ Ghent, Dept Cardiovasc Dis, B-9000 Ghent, Belgium
[2] Acad Hosp St Jan, Dept Lab Med, Asklepios Core Lab, Brugge, Belgium
[3] Univ Ghent, Dept Clin Chem, B-9000 Ghent, Belgium
[4] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium
来源：
ATHEROSCLEROSIS | 2013年 / 226卷 / 01期
关键词：
HDL-cholesterol; Cardiovascular risk; SCORE; HDL subclasses; Analytical variation; Standardization; DENSITY-LIPOPROTEIN CHOLESTEROL; APOLIPOPROTEIN-B; DISEASE; ULTRACENTRIFUGATION; STANDARDIZATION; HETEROGENEITY; IMPACT; ASSAY;
D O I：
10.1016/j.atherosclerosis.2012.10.036
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：296 / 298
页数：3
相关论文
共 22 条
  • [1] High-density lipoprotein function - Recent advances
    Ansell, BJ
    Watson, KE
    Fogelman, AM
    Navab, M
    Fonarow, GC
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (10) : 1792 - 1798
  • [2] ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
    Catapano, Alberico L.
    Reiner, Zeljko
    De Backer, Guy
    Graham, Ian
    Taskinen, Marja-Riitta
    Wiklund, Olov
    Agewall, Stefan
    Alegria, Eduardo
    Chapman, M. John
    Durrington, Paul
    Erdine, Serap
    Halcox, Julian
    Hobbs, Richard
    Kjekshus, John
    Filardi, Pasquale Perrone
    Riccardi, Gabriele
    Storey, Robert F.
    Wood, David
    [J]. ATHEROSCLEROSIS, 2011, 217 (01) : 3 - 46
  • [3] Cobbaert C, 1998, CLIN CHEM, V44, P779
  • [4] Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement
    Contois, John H.
    Warnick, G. Russell
    Sniderman, Allan D.
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2011, 5 (04) : 264 - 272
  • [5] HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk
    Cooney, M. T.
    Dudina, A.
    De Bacquer, D.
    Wilhelmsen, L.
    Sans, S.
    Menotti, A.
    De Backer, G.
    Jousilahti, P.
    Keil, U.
    Thomsen, T.
    Whincup, P.
    Graham, I. M.
    [J]. ATHEROSCLEROSIS, 2009, 206 (02) : 611 - 616
  • [6] The prevalence of concomitant hypertension and hypercholesterolaemia in the general population
    De Bacquer, Dirk
    De Backer, Guy
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 110 (02) : 217 - 223
  • [7] A simple multiplier to calculate the impact of HDL cholesterol on cardiovascular risk estimation using SCORE
    Descamps, Olivier S.
    Cooney, Marie Therese
    De Backer, Guy
    Graham, Ian
    [J]. ATHEROSCLEROSIS, 2012, 222 (02) : 564 - 566
  • [8] LCAT, HDL Cholesterol and Ischemic Cardiovascular Disease: A Mendelian Randomization Study of HDL Cholesterol in 54,500 Individuals
    Haase, Christiane L.
    Tybjaerg-Hansen, Anne
    Qayyum, Abbas Ali
    Schou, Jesper
    Nordestgaard, Borge G.
    Frikke-Schmidt, Ruth
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (02) : E248 - E256
  • [9] Comparison of a homogeneous assay with a precipitation method for the measurement of HDL cholesterol in diabetic patients
    Jensen, T
    Truong, Q
    Frandsen, M
    Dinesen, B
    Stender, S
    [J]. DIABETES CARE, 2002, 25 (11) : 1914 - 1918
  • [10] Kimberly MM, 1999, CLIN CHEM, V45, P1803
123